Form 4: Bristol-Myers Squibb Executive Karin Shanahan Reports Stock Transactions

EVP Karin Shanahan reports acquisition and disposal of Bristol-Myers Squibb common stock and restricted stock units on April 1, 2025.

Summary

• Karin Shanahan, an Executive Vice President at Bristol-Myers Squibb, filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
• On April 1, 2025, Shanahan acquired 3,306 shares of common stock through the vesting of restricted stock units.
• Also on April 1, 2025, 1,692 shares were withheld for payment of taxes upon the vesting of awards at a price of $59.55.
• Following these transactions, Shanahan directly owns 13,797 shares of common stock and indirectly owns 1,278.692 shares through the BMS Savings and Investment Program.
• She also directly owns 3,307 restricted stock units.
• The restricted stock units vest in four equal annual installments beginning on April 1, 2023, and each unit converts into one share of common stock upon vesting.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The vesting of restricted stock units indicates a form of compensation and alignment of interests between the executive and the company's performance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates the executive's transactions in the company's stock, which is common for executives with stock-based compensation.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units that vest over time, aligning executive interests with long-term shareholder value, similar to practices at companies like Pfizer (PFE) and Johnson & Johnson (JNJ).
• The tax withholding process is standard practice across publicly traded companies to cover income tax obligations arising from the vesting of equity awards.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax obligations.

Key Dates

Keywords

Form 4, Bristol-Myers Squibb, Karin Shanahan, Stock, Restricted Stock Units, Beneficial Ownership, BMY